Insiders · Profile

Bizily Scott

Chief Legal Officer at 4D Molecular Therapeutics. Filing since 1 Dec 2022. CIK 0001920738

Company

Date

Role

Action

Shares

Amount

Of holding

FDMT 4D Molecular Therapeutics, Inc.

16 Sep 2026

Chief Legal Officer

Sold on a plan

1,635

$22.32K

15.9%

FDMT 4D Molecular Therapeutics, Inc.

1 Sep 2026

Chief Legal Officer

Sold on a plan

584

$8.18K

6.3%

FDMT 4D Molecular Therapeutics, Inc.

17 Aug 2026

Chief Legal Officer

Sold on a plan

1,635

$19.95K

15.9%

FDMT 4D Molecular Therapeutics, Inc.

13 Aug 2026

Chief Legal Officer

Sold on a plan

1,635

$19.62K

15.9%

FDMT 4D Molecular Therapeutics, Inc.

30 Jun 2026

Chief Legal Officer

Sold on a plan

6,566

$91.92K

43.2%

FDMT 4D Molecular Therapeutics, Inc.

23 Jun 2026

Chief Legal Officer

Sold on a plan

9,810

$117.72K

53.2%

FDMT 4D Molecular Therapeutics, Inc.

16 Dec 2025

Chief Legal Officer

Sold on a plan

1,635

$17.82K

31.3%

FDMT 4D Molecular Therapeutics, Inc.

17 Nov 2025

Chief Legal Officer

Sold on a plan

1,635

$17.31K

31.3%

FDMT 4D Molecular Therapeutics, Inc.

24 Oct 2025

Chief Legal Officer

Sold on a plan

2,678

$32.14K

42.7%

FDMT 4D Molecular Therapeutics, Inc.

16 Oct 2025

Chief Legal Officer

Sold on a plan

1,635

$16.63K

24.0%

FDMT 4D Molecular Therapeutics, Inc.

9 Oct 2025

Chief Legal Officer

Sold on a plan

2,408

$24.08K

31.7%

FDMT 4D Molecular Therapeutics, Inc.

23 Sep 2025

Chief Legal Officer

Sold on a plan

2,407

$19.26K

24.1%

FDMT 4D Molecular Therapeutics, Inc.

16 Sep 2024

Chief Legal Officer

Sold on a plan

500

$8.17K

6.9%

FDMT 4D Molecular Therapeutics, Inc.

19 Aug 2024

Chief Legal Officer

Sold on a plan

500

$7.50K

6.9%

FDMT 4D Molecular Therapeutics, Inc.

16 Jul 2024

Chief Legal Officer

Sold on a plan

1,750

$47.44K

20.5%

FDMT 4D Molecular Therapeutics, Inc.

11 Jul 2024

Chief Legal Officer

Sold on a plan

1,996

$49.90K

22.7%

FDMT 4D Molecular Therapeutics, Inc.

1 Jul 2024

Chief Legal Officer

Sold on a plan

4,248

$90.76K

71.0%

FDMT 4D Molecular Therapeutics, Inc.

17 Jun 2024

Chief Legal Officer

Sold on a plan

1,750

$41.49K

50.2%

FDMT 4D Molecular Therapeutics, Inc.

16 May 2024

Chief Legal Officer

Sold on a plan

1,750

$44.54K

50.2%

FDMT 4D Molecular Therapeutics, Inc.

16 Apr 2024

Chief Legal Officer

Sold on a plan

1,750

$45.05K

50.2%

FDMT 4D Molecular Therapeutics, Inc.

1 Apr 2024

Chief Legal Officer

Sold on a plan

8,153

$259.10K

82.4%

FDMT 4D Molecular Therapeutics, Inc.

27 Mar 2024

Chief Legal Officer

Sold on a plan

5,833

$204.41K

77.1%

FDMT 4D Molecular Therapeutics, Inc.

18 Mar 2024

Chief Legal Officer

Sold on a plan

1,750

$54.72K

50.2%

FDMT 4D Molecular Therapeutics, Inc.

27 Feb 2024

Chief Legal Officer

Sold on a plan

1,909

$57.27K

52.4%

FDMT 4D Molecular Therapeutics, Inc.

16 Feb 2024

Chief Legal Officer

Sold on a plan

1,750

$48.42K

50.2%

FDMT 4D Molecular Therapeutics, Inc.

8 Feb 2024

Chief Legal Officer

Sold on a plan

6,244

$171.71K

78.2%

FDMT 4D Molecular Therapeutics, Inc.

8 Jun 2023

Chief Legal and HR Officer

Sold at will

3,750

$78.19K

68.3%

FDMT 4D Molecular Therapeutics, Inc.

1 Jun 2023

Chief Legal and HR Officer

Sold at will

2,247

$41.14K

56.4%

FDMT 4D Molecular Therapeutics, Inc.

21 Apr 2023

Chief Legal and HR Officer

Sold on a plan

3,750

$75.00K

64.0%

FDMT 4D Molecular Therapeutics, Inc.

1 Mar 2023

Chief Legal and HR Officer

Sold, plan not stated

2,248

$43.39K

51.6%

FDMT 4D Molecular Therapeutics, Inc.

1 Dec 2022

Chief Legal and HR Officer

Sold, plan not stated

6,000

$136.73K

70.7%

31 decisions on file.